Replies to post #107492 on Avid Bioservices Inc (CDMO)

[Seagull2]

It appears that Avastin has some adverse side effects that while treating various cancers, it's efficacy is not very good. Dr Garnick has said that he thinks Bavi is much safer (has less side effects) and if Mos is equal too or better than Avastin, Bavi should be on the fast trac for approval soon. In your humble opinion, based on the clinical results to date, do you think that Bavi will be equal too or superior to Avastin in Mos when all the results are in. Let me know what you think. Thanks.

GULL

[Protector]

That means that only with he clinical trials that we have today 40% of Avastin's approvals are challenged by Bavi and Cotara (NSCLC-Bavi and Glioblastoma probably by Cotara (assuming GMBH).

With Breast already removed from the market by the FDA it surely looks like they would better stop the remaining 450+ trials of about 1500 for Avastin and channel that money to Peregrine partnerships.